"Το Βενιζέλειο Γενικό Νοσοκομείο Ηρακλείου (ΒΓΝΗ), είναι το ιστορικότερο νοσοκομείο του Ηρακλείου, ενταγμένο στο Εθνικό Σύστημα Υγείας, ενώ υπάγεται στην 7η Υγειονομική Περιφέρεια (Κρήτης) και παρέχει πρωτοβάθμια, δευτεροβάθμια και τριτοβάθμια περίθαλψη, ισότιμα σε κάθε πολίτη, ανεξάρτητα από την οικονομική, κοινωνική και επαγγελματική του κατάσταση. Ορισμένοι σημαντικοί δείκτες που δείχνουν το ποιοτικό του επίπεδο είναι η υψηλή πληρότητα, η χαμηλή μέση διάρκεια νοσηλείας, οι χαμηλοί δείκτες επίπτωσης σε λοιμώξεις σχετιζόμενες με υγειονομικό χώρο, το σχετικά χαμηλό κόστος ανά ημέρα νοσηλείας, ορισμένα κέντρα/μονάδες που δεν υπάρχουν σε άλλη μονάδα υγείας στην Κρήτη και η γενική εντύπωση ότι το Βενιζέλειο είναι «το νοσοκομείο της καρδιάς"."

During the past decade, General Hospital of Heraklion Benizeleio Pananeio conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "General Hospital of Heraklion Benizeleio Pananeio" #1 sponsor was "Celgene" with 2 trials, followed by "Centre Hospitalier Universitaire de Saint Etienne" with 1 trials sponsored, "Janssen-Cilag International NV" with 1 trials sponsored, "Novartis Pharmaceuticals" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "General Hospital of Heraklion Benizeleio Pananeio" are "Ulcerative Colitis" (2 trials), "Alzheimer Disease" (1 trials), "Crohn Disease" (1 trials), "Depressive Disorder, Major" (1 trials) and "Diamond Blackfan Anemia" (1 trials). Many other conditions were trialed in "General Hospital of Heraklion Benizeleio Pananeio" in a lesser frequency.

Most popular intervention types in "General Hospital of Heraklion Benizeleio Pananeio" are "Drug" (6 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "5-ASA" (1 trials), "CC-90001" (1 trials), "Corticosteroids" (1 trials) and "Deferasirox" (1 trials). Other intervention names were less common.

The vast majority of trials in "General Hospital of Heraklion Benizeleio Pananeio" are 7 trials for "All" genders.

Currently, there are NaN active trials in "General Hospital of Heraklion Benizeleio Pananeio". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in General Hospital of Heraklion Benizeleio Pananeio, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in General Hospital of Heraklion Benizeleio Pananeio, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".